Chronic Pain and Hepatitis C Virus Infection in Opioid Dependent Injection Drug Users

被引:16
|
作者
Tsui, Judith I. [1 ]
Herman, Debra S. [2 ,3 ]
Kettavong, Malyna [2 ,3 ]
Anderson, Bradley J. [2 ,3 ]
Stein, Michael D. [2 ,3 ]
机构
[1] Boston Univ, Sch Med, Boston Med Ctr, Boston, MA 02118 USA
[2] Brown Univ, Butler Hosp, Providence, RI 02912 USA
[3] Brown Univ, Warren Alpert Sch Med, Providence, RI 02912 USA
关键词
Hepatitis C virus; injection drug use; chronic pain; pain hypersensitivity; NECROSIS-FACTOR-ALPHA; METHADONE-MAINTENANCE PATIENTS; DEPRESSIVE SYMPTOMS; PANIC DISORDER; HIV; PREVALENCE; INTERLEUKIN-6; ASSOCIATION; RESPONSES; INTOLERANCE;
D O I
10.1080/10550887.2011.554775
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
It is unknown whether infection with hepatitis C is a risk factor for pain among people who have used injection drugs. Multivariate regression was used to determine whether hepatitis C was associated with greater likelihood of reporting significant chronic pain and discomfort intolerance in a cohort of 97 injection drug users dependent on opioids. Study results suggest that participants with hepatitis C may be more likely to experience chronic pain (aOR = 1.98; 95% confidence interval = 0.76 to 5.12, p= 0.16). Furthermore, hepatitis C was found to be associated with a higher discomfort intolerance scale score, reflecting intolerance to physical discomfort (= 2.34; 95% confidence interval = 0.06 to 4.62; p= 0.04). Hepatitis C may be a cause for chronic pain and discomfort intolerance that is overlooked among injection drug users dependent on opioids.
引用
收藏
页码:91 / 97
页数:7
相关论文
共 50 条
  • [1] Recommendations for the management of hepatitis C virus infection in injection drug users
    Grebely, Jason
    Robaeys, Geert
    Bruggmann, Philip
    Aghemo, Alessio
    Backmund, Markus
    Bruneau, Julie
    Byrne, Jude
    Dalgard, Olav
    Feld, Jordan J.
    Hellard, Margaret
    Hickman, Matthew
    Kautz, Achim
    Litwin, Alain
    Lloyd, Andrew R.
    Mauss, Stefan
    Prins, Maria
    Swan, Tracy
    Schaefer, Martin
    Taylor, Lynn E.
    Dore, Gregory J.
    [J]. INTERNATIONAL JOURNAL OF DRUG POLICY, 2023, 111
  • [2] Acute hepatitis C virus infection in incarcerated injection drug users
    McGovern, Barbara H.
    Wurcel, Alysse
    Kim, Arthur Y.
    zur Wiesch, Julian Schulze
    Bica, Ioana
    Zaman, M. Tauheed
    Timm, Joerg
    Walker, Bruce D.
    Lauer, Georg M.
    [J]. CLINICAL INFECTIOUS DISEASES, 2006, 42 (12) : 1663 - 1670
  • [3] Associations between prescription opioid injection and Hepatitis C virus among young injection drug users
    Lankenau, Stephen
    Kecojevic, Aleksandar
    Silva, Karol
    [J]. DRUGS-EDUCATION PREVENTION AND POLICY, 2015, 22 (01) : 35 - 42
  • [4] Association of Opioid Agonist Therapy With Lower Incidence of Hepatitis C Virus Infection in Young Adult Injection Drug Users
    Tsui, Judith I.
    Evans, Jennifer L.
    Lum, Paula J.
    Hahn, Judith A.
    Page, Kimberly
    [J]. JAMA INTERNAL MEDICINE, 2014, 174 (12) : 1974 - 1981
  • [5] Hepatitis C virus reinfection in injection drug users
    Grebely, Jason
    Conway, Brian
    Raffa, Jesse D.
    Lai, Calvin
    Krajden, Mel
    Tyndall, Mark W.
    [J]. HEPATOLOGY, 2006, 44 (05) : 1139 - 1145
  • [6] Treatment of hepatitis C infection in injection drug users
    Backmund, M
    Meyer, K
    Von Zielonka, M
    Eichenlaub, D
    [J]. HEPATOLOGY, 2001, 34 (01) : 188 - 193
  • [7] High prevalence of occult hepatitis C virus infection in injection drug users with HIV infection
    Donyavi, Tahereh
    Bokharaei-Salim, Farah
    Khanaliha, Khadijeh
    Sheikh, Maryam
    Bastani, Mohammad-Navid
    Moradi, Najmeh
    Babaei, Roghayeh
    Habib, Zahra
    Fakhim, Atousa
    Esghaei, Maryam
    [J]. ARCHIVES OF VIROLOGY, 2019, 164 (10) : 2493 - 2504
  • [8] High prevalence of occult hepatitis C virus infection in injection drug users with HIV infection
    Tahereh Donyavi
    Farah Bokharaei-Salim
    Khadijeh Khanaliha
    Maryam Sheikh
    Mohammad-Navid Bastani
    Najmeh Moradi
    Roghayeh Babaei
    Zahra Habib
    Atousa Fakhim
    Maryam Esghaei
    [J]. Archives of Virology, 2019, 164 : 2493 - 2504
  • [9] Factors associated with hepatitis C virus infection in injection and noninjection drug users in Italy
    Quaglio, G
    Lugoboni, F
    Pajusco, B
    Sarti, M
    Talamini, G
    Lechi, A
    Mezzelani, P
    Jarlais, DCD
    [J]. CLINICAL INFECTIOUS DISEASES, 2003, 37 (01) : 33 - 40
  • [10] Treatment for hepatitis C virus infection among current injection drug users in Australia
    Matthews, G
    Kronborg, IJ
    Dore, GJ
    [J]. CLINICAL INFECTIOUS DISEASES, 2005, 40 : S325 - S329